Preference for Inebilizumab Home Infusion Among People with Neuromyelitis Optica Spectrum Disorder (P12-8.003)
To determine whether people with neuromyelitis optica spectrum disorder (NMOSD) prefer to receive inebilizumab (Uplizna) infusions at home versus in an infusion center or hospital, and to assess how that choice affects their quality of life.
Authors
- Gabriela Romanow
- Michaël Levy (ORCID: https://orcid.org/0000-0003-2766-5777)
- Gerome Vallejos (ORCID: https://orcid.org/0000-0001-6006-3909)
Institutions
- Harvard University (US)
- Massachusetts General Hospital (US)
Publication Details
- Journal
- Neurology
- Published
- 2025-04-07
- DOI
- https://doi.org/10.1212/wnl.0000000000208932
- Primary Topic
- Multiple Sclerosis Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00